Skip to content

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Down Syndrome | Fetal Aneuploidy

The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

null

Participation Requirements

  • Sex:

    FEMALE

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* pregnant between 10 and 22 weeks gestation
* 18 years of age or older
* provides signed and dated informed consent
* subject is at increased risk for fetal aneuploidy
* subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis
* subject agrees to provide the genetic results of the invasive procedure

Exclusion Criteria:

* Fetal demise at time of specimen sampling
* Previous sample donation under this protocol

Study Location

North York General Hospital
North York General Hospital
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Wendy Meschino, MD

Primary Contact

Clare Gibbons

[email protected]
416 756-6788
IWK Health Centre
IWK Health Centre
Halifax, Nova Scotia
Canada

Contact Study Team

Primary Contact

Cora Fanning

[email protected]
902 470-7158
Backup Contact

Jo-Ann Brock, MD

Study Sponsored By
Sequenom, Inc.
Participants Required
More Information
Study ID: NCT01429389